Patton Fund Management, Inc. Pfizer Inc Transaction History

Patton Fund Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $18,161 - $23,707	-435 Reduced 1.28%	33,447 $1.71 Million
Q3 2022 Oct 21, 2022	SELL	$43.76 - $53.42 $126,378 - $154,276	-2,888 Reduced 7.85%	33,882 $1.48 Million
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $1.24 Million - $1.47 Million	-26,595 Reduced 41.97%	36,770 $1.93 Million
Q1 2022 Apr 20, 2022	SELL	$45.75 - $56.69 $102,891 - $127,495	-2,249 Reduced 3.43%	63,365 $3.28 Million
Q4 2021 Jan 21, 2022	BUY	$41.32 - $61.25 $2.71 Million - $4.02 Million	65,614 New	65,614 $3.88 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Patton Fund Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Patton Fund Management, Inc. with notifications on news.